A case of ovarian small cell carcinoma of the pulmonary type that was observed as it developed

In the case reported here, the authors observed ovarian small cell carcinoma of the pulmonary type as it developed. The patient was a 48-year-old woman who underwent a hysterectomy for CIN3 in 2007. A year later, the woman underwent screening for ovarian cancer. A gradually growing ovarian mass was noted. This mass was found to be a mixed tumor. This mixed tumor grew to 36 mm in size, and six months later it had enlarged to 119 mm. After surgery, the tumor was pathologically diagnosed as an ovarian small cell carcinoma of the pulmonary type with a neuroendocrine nature that was positive for CD56 and synaptophysin. Postoperatively, the patient received six courses of combined therapy with irinotecan and cisplatin (CPT-P therapy), and the patient has survived diseasefree for over two years. Findings suggested that ovarian small cell carcinoma of the pulmonary type is a type 1 ovarian malignancy that develops through an adenoma-carcinoma sequence.

Ovarian small cell carcinoma; Pulmonary type; Type 1 ovarian malignancy; CD56; Synaptophysin; Irinotecan and cisplatin.

[1] Scully R.E.: “Small cell carcinoma of hypercalcemic type”. Int. J. Gynecol. Pathol., 1993, 12, 148.

[2] Kurman R.J., Shih IeM.: “Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications”. Int. J. Gynecol. Pathol., 2008, 27, 151.

[3] Dickersin G.R., Kline I.W., Scully R.E.: “Small cell carcinoma of the ovary with hypercalcemia: a report of eleven cases”. Cancer, 1982, 49, 188.

[4] Young R.H., Esther O., Scully R.E.: “Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases”. Am. J. Surg. Pathol., 1994, 18, 1102.

[5] Eichhorn J.H., Young R.H., Scully R.E.: “Primary ovarian small cell carcinoma of pulmonary type. Aclinicopathologic, immunohistologic, and flow cytometric analysis of 11 cases”. Am. J. Surg. Pathol., 1992, 16, 926.

[6] Van der Heijden H.F., Heijdra Y.F.: “Extraplumonary small cell carcinoma”. South Med. J., 2005, 98, 345.

[7] Eichhorn J.H., Young R.H., Scully R.E.: “Nonpulumonary small cell carcinomas of extragenital origin metastatic to the ovary”. Cancer, 1993, 71, 177.

[8] Frazier S.R., Kaplan P.A., Loy T.S.: “The pathology of extrapulumonary small cell carcinoma”. Semin. Oncol., 2007, 34, 30.

[9] Saitoh-Sekiguchi M., Nakamura K., Kojimahara T., Ohta T., Kawagoe J., Ohnuki T., et al.: “Complete remission of ovarian small cell carcinoma treated with irinotecan and cisplatin: a case report”. Anticancer Res., 2007, 27, 2685.

[10] Niimi S., Kiyokawa T., Takakura S., Ochiai K., Tanaka T.: “Recurrent small cell carcinoma of the ovary treated with docetaxel: a casereport”. Int. J. Gynecol. Cancer, 2006, 16, 1944.

[11] Isonishi S., Nishii H., Saitou M., Yasuda M., Kiyokawa T., Fukunaga M., et al.: “Small cell carcinoma of the ovary: clinical and biological study”. Int. J. Clin. Oncol., 2008, 13, 161.

[12] Crowder S., Tuller E.: “Small cell carcinoma of the female genital tract”. Semin. Oncol., 2007, 34, 57.